Position in PBYI
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$1,616,919
-$87,809 QoQ
Shares Held
253,039
-11.7% QoQ
Ownership
0.497%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2020
22 quarters on record
Voting authority
Sole 99%
Shared 0%
None 1%
Common Shares in PBYI Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026PRUDENTIAL FINANCIAL INC holds $492,173,260 across 170 Biotechnology names. PBYI ranks #52 (0.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
140,491 | $108,548,965 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
131,560 | $58,746,801 | |
| 3 | INCY |
Incyte Corp
|
374,280 | $35,227,233 | |
| 4 | EXEL |
Exelixis, Inc.
|
463,825 | $19,893,454 | |
| 5 | LGND |
Ligand Pharmaceuticals Inc
|
64,133 | $12,804,153 | |
| 6 | ALMS |
Alumis Inc.
|
538,733 | $11,868,287 | |
| 7 | PTCT |
Ptc Therapeutics, Inc.
|
164,570 | $11,212,154 | |
| 8 | PTGX |
Protagonist Therapeutics, Inc
|
95,235 | $10,037,769 |
All Filings in PBYI
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,616,919 | 253,039 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $1,704,728 | 286,509 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $1,173,212 | 220,944 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $964,666 | 281,244 | Shares | Defined | 2025-08-12 | |
| 2025-03-31 | $912,138 | 308,155 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $324,169 | 106,285 | Shares | Defined | 2025-02-11 | |
| 2024-09-30 | $256,236 | 100,485 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $57,327 | 17,585 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $80,560 | 15,200 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $71,012 | 16,400 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $43,132 | 16,400 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $57,892 | 16,400 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $50,676 | 16,400 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $44,838 | 10,600 | Shares | Defined | 2023-02-14 | |
| 2022-03-31 | $538,375 | 186,936 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $542,445 | 178,436 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $2,521,461 | 359,695 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $3,531,885 | 384,737 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $2,496,912 | 256,884 | Shares | Defined | 2021-05-12 | |
| 2020-12-31 | $2,915,080 | 284,121 | Shares | Defined | 2021-08-16 | |
| 2020-09-30 | $3,496,396 | 346,521 | Shares | Defined | 2020-11-16 | |
| 2020-06-30 | $1,066,790 | 102,281 | Shares | Defined | 2020-08-12 | |
| No filing history on record for this holder in this stock. | ||||||